Celia Trifilio, PHYSICIAN ASSISTANT - Medicare Physician Assistant in Provo, UT

Celia Trifilio, PHYSICIAN ASSISTANT is a medicare enrolled "Physician Assistant" physician in Provo, Utah. She graduated from medical school in 2019 and has 5 years of diverse experience with area of expertise as Physician Assistant. She is a member of the group practice Central Utah Clinic Pc and her current practice location is 1055 N 500 W # 207, Provo, Utah. You can reach out to her office (for appointments etc.) via phone at (801) 375-4263.

Celia Trifilio is licensed to practice in Utah (license number 11484934-1206) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1871139048.

Contact Information

Celia Trifilio, PHYSICIAN ASSISTANT
1055 N 500 W # 207,
Provo, UT 84604-3305
(801) 375-4263
Not Available



Physician's Profile

Full NameCelia Trifilio
GenderFemale
SpecialityPhysician Assistant
Experience5 Years
Location1055 N 500 W # 207, Provo, Utah
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Celia Trifilio graduated from medical school in 2019
  NPI Data:
  • NPI Number: 1871139048
  • Provider Enumeration Date: 11/22/2019
  • Last Update Date: 07/20/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 1557767811
  • Enrollment ID: I20210913000079

Medical Identifiers

Medical identifiers for Celia Trifilio such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1871139048NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 11484934-1206 (Utah)Secondary
363A00000XPhysician Assistant 11484934-1206 (Utah)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Central Utah Clinic Pc7517868508391

News Archive

Study points to future treatment for post-stroke damage

A study of rats released today shows that blocking a type of RNA produced by what used to be called "junk DNA" can prevent a significant portion of the neural destruction that follows a stroke. The research points toward a future treatment for post-stroke damage, which is often more extensive than the initial destruction that results when blood to the brain is temporarily shut off.

Many studies overlook hearing loss when assessing doctor-patient communication

Doctors believe that communication with those under their care is important, but most studies of communication between physicians and older adults do not mention that hearing loss may affect this interaction. The findings come from a review published in the Journal of the American Geriatrics Society.

Saturday night vote set on house health reform

The Washington Post reports: "Democratic whips worked their rank and file, while House leaders tried to secure a momentum-building endorsement from the AARP, the nation's largest association of people over 50. President Obama, meanwhile, laid plans to visit Capitol Hill on Thursday or Friday to address House Democrats in a final push for his signature domestic initiative.

Over 700 Chinese patients with acute myeloid leukemia undergo Microtransplantation treatment

According to Dr. Huisheng Ai's team, founder of Microtransplantation regimen mainly for Acute Myeloid Leukemia, over 700 patients have undergone this therapy since its emergence in 2002. Based at MST International Clinic for Leukemia in the 307th Hospital of Chinese People's Liberation Army in Beijing, about 40 hematology centers covering all main hospitals in 32 provinces of mainland China have adopted Microtransplantation regimen.

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Celia Trifilio is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Celia Trifilio, PHYSICIAN ASSISTANT
1055 N 500 W, Attn Credentialing,
Provo, UT 84604

Ph: (801) 354-8225
Celia Trifilio, PHYSICIAN ASSISTANT
1055 N 500 W # 207,
Provo, UT 84604-3305

Ph: (801) 375-4263

News Archive

Study points to future treatment for post-stroke damage

A study of rats released today shows that blocking a type of RNA produced by what used to be called "junk DNA" can prevent a significant portion of the neural destruction that follows a stroke. The research points toward a future treatment for post-stroke damage, which is often more extensive than the initial destruction that results when blood to the brain is temporarily shut off.

Many studies overlook hearing loss when assessing doctor-patient communication

Doctors believe that communication with those under their care is important, but most studies of communication between physicians and older adults do not mention that hearing loss may affect this interaction. The findings come from a review published in the Journal of the American Geriatrics Society.

Saturday night vote set on house health reform

The Washington Post reports: "Democratic whips worked their rank and file, while House leaders tried to secure a momentum-building endorsement from the AARP, the nation's largest association of people over 50. President Obama, meanwhile, laid plans to visit Capitol Hill on Thursday or Friday to address House Democrats in a final push for his signature domestic initiative.

Over 700 Chinese patients with acute myeloid leukemia undergo Microtransplantation treatment

According to Dr. Huisheng Ai's team, founder of Microtransplantation regimen mainly for Acute Myeloid Leukemia, over 700 patients have undergone this therapy since its emergence in 2002. Based at MST International Clinic for Leukemia in the 307th Hospital of Chinese People's Liberation Army in Beijing, about 40 hematology centers covering all main hospitals in 32 provinces of mainland China have adopted Microtransplantation regimen.

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

Read more News

› Verified 2 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.